Uploaded November 2026 | Updated November 2026, 1 hour ago
Between 27m and 36m people in the EU live with a rare disease. These illnesses are no longer a niche issue in life sciences; they are shaping the direction of advanced therapies, personalised care and faster diagnosis. Yet many patients still depend on specialist networks and cross-border care to reach the expertise they need. The EU’s European Reference Networks were created precisely because expertise for rare and complex diseases is often scattered across countries rather than concentrated within one system. As innovation produces new treatment possibilities, what will it take for health systems to keep pace, invest in this area and translate breakthroughs into access?
Moderator: Graham Cookson, chief executive, Office of Health Economics
Sheela Upadhyaya, founder, Rarely Ordinary
Virginie Hivert, head of therapies and access, EURODIS
Muneeb Khan, deputy chief marketing officer, King Faisal Specialist Hospital & Research Centre
(virtual) Daria Julkowska, strategy and partnerships in health lead, European Rare Diseases Research Alliance
Between 27m and 36m people in the EU live with a rare disease. These illnesses are no longer a niche issue in life sciences; they are shaping the direction of advanced therapies, personalised care and faster diagnosis. Yet many patients still depend on specialist networks and cross-border care to reach the expertise they need. The EU’s European Reference Networks were created precisely because expertise for rare and complex diseases is often scattered across countries rather than concentrated within one system. As innovation produces new treatment possibilities, what will it take for health systems to keep pace, invest in this area and translate breakthroughs into access?
Moderator: Graham Cookson, chief executive, Office of Health Economics
Sheela Upadhyaya, founder, Rarely Ordinary
Virginie Hivert, head of therapies and access, EURODIS
Muneeb Khan, deputy chief marketing officer, King Faisal Specialist Hospital & Research Centre
(virtual) Daria Julkowska, strategy and partnerships in health lead, European Rare Diseases Research Alliance










